Xipoint Pharmaceuticals: Company's protein succinic acid iron has obtained the approval notice for the application for listing of chemical raw materials.

West Point Pharmaceutical announced on March 26 that the company has recently received the "Notice of Approval for Market Application of Ferrous Protein Succinate" issued by the National Medical Products Administration. Ferrous Protein Succinate is an iron supplement used for absolute and relative iron-deficient anemia caused by insufficient iron intake or absorption disorders, acute or chronic bleeding, and infections during pregnancy and lactation.